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Abstract 
 
Rationale: It is well-established that nicotine improves, and deprivation impairs, cognitive 
performance and mood in smokers.  Prospective memory (PM), remembering to execute a 
delayed intention at a given time point, is under-explored in smokers.  Whilst a handful of 
studies have shown improved PM with nicotine, effects of nicotine delivered via the 
electronic cigarette have not been investigated.  
Objective: This study explores whether, by comparison with placebo, nicotine delivered via 
the e-cigarette can improve PM, tobacco withdrawal symptoms and desire to smoke in 
abstinent smokers.   
Methods: Twenty smokers, abstinent for 8-10 hours, each completed two experimental 
sessions under nicotine (18mg) and placebo (0mg) e-cigarette conditions.  Participants 
completed a single-item desire to smoke scale and the Mood and Physical Symptoms Scale 
(MPSS).  PM was measured using the Cambridge Prospective Memory Test (CAMPROMPT). 
Results: Compared with placebo, the nicotine e-cigarette reduced desire to smoke and 
tobacco withdrawal symptoms, and improved time-based but not event-based PM.  There 
was a moderate, marginally significant negative correlation between PM performance 
during abstinence and nicotine dependence.   
Conclusions: This is the first study to show that nicotine derived via e-cigarette can improve 
PM in abstinent smokers suggesting efficient nicotine delivery.  That the effect of nicotine 
was restricted to time-based rather than event-based PM is consistent with the view that 
nicotine acts to improve performance on strategic (effortful) rather than automatic 
processing.  These findings add to the growing body of evidence that the e-cigarette can 
replace some of the effects of nicotine derived from tobacco smoking thus highlighting its 
potential for smoking cessation.   
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Introduction 
  
Abstinence from smoking, whether as part of a quit attempt or associated with enforcement 
of non-smoking laws, is accompanied by tobacco withdrawal symptoms including cigarette 
craving/desire to smoke, irritability, anxiety, depression and difficulty concentrating 
(American Psychiatric Association [APA] 2000; Hughes, 2007).  Smokers commonly believe 
that smoking improves attention, alertness and concentration (West, 1993) and such 
perceived benefits have been suggested to motivate continued smoking (Heishman et al. 
2010).  A plethora of studies have demonstrated that smoking can improve, and deprivation 
impair, performance on a variety of cognitive domains including reaction time (Bates et al. 
1995; Giannakoulas et al. 2003; Perkins et al. 1995), vigilance/attention (Bell et al. 1999; 
Gilbert et al. 1997), inhibitory control (Powell et al. 2001), learning (Soar et al. 2008), and 
working memory (Jacobsen et al. 2005; Merritt et al. 2012).  Nicotine replacement therapy 
(NRT) is also associated with attenuation of tobacco withdrawal symptoms (Kleykamp et al. 
2008; Shiffman et al. 2006) and improved cognitive performance in abstinent smokers.  Thus 
sustained attention (Mancuso et al. 1999; Parrot and Craig 1992) and working memory 
(Atzori et al. 2008; Grobe et al. 1998) are improved after NRT compared with placebo, 
although there are also some negative findings (Ahnallen et al. 2008; Cook et al. 2003; 
Warburton and Mancuso 1998). 
 
Nicotine is a cholinergic agonist, binding to presynaptic nicotinic acetylcholine receptors 
(nAChRs) in turn facilitating the release of a number of neurotransmitters including 
acetylcholine, dopamine, serotonin and glutamate (Di Matteo et al. 2007).  The cholinergic 
neurotransmitter system is generally considered to play a pivotal role in memory and 
attention modulation (Kruk-Slomka et al. 2012; Robins and Roberts 2007).  Thus nicotinic 
activation of the prefrontal cortex, parietal cortex, thalamus and hippocampus - areas dense 
in nicotinic acetylcholine receptors - is thought to mediate its effects on memory and 
attention (Levin et al. 2006).  
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Whilst studies on the effects of abstinence and nicotine administration on working memory 
abound, prospective memory has received very little attention.  Prospective memory (PM) 
refers to the intention or plan to perform a particular action at some point in the future.  
This ability to remember to perform a delayed intention is critical to the efficiency of our 
everyday lives, has been shown to decline with advancing age (Maylor 1996) and is worse in 
smokers than non-smokers (Heffernan et al. 2005; Heffernan et al. 2010).  PM, however, is 
not a unitary process; it involves encoding and maintaining an intention and retrieving and 
executing it at the appropriate moment in the future. Neuroimaging studies strongly 
implicate the rostral prefrontal cortex (Brodmann Area [BA] 10) in PM as well fronto-parietal 
networks including the inferior parietal lobe (BA 40), precuneus (BA 7), and anterior 
cingulate (BA 32), regions activated in a wide range of tasks engaging attention, executive 
functions and working memory (Burgess 2011). Thus PM likely draws on attentional, 
executive and working memory resources; indeed, previous studies have found a positive 
relationship between working memory span and PM performance (Smith and Bayen 2005; 
Smith et al., 2011). 
 
 Empirical studies exploring PM functioning have focused on event-based and time-based 
intentions as both prove to be amenable to laboratory control. Event based PM tasks are 
characterized by a pre-designated target cue in the environment that when detected, 
reminds the individual to execute an intention. In contrast, time based intentions must be 
executed after a specified period of time has elapsed. In both types of PM paradigm, an on-
going distractor task is employed to engage attention and allow the necessary delay 
required between encoding the intention and executing the action in response to the target 
cue/elapsed time.  Both strategic and automatic processes are thought to be involved in the 
retrieval of intentions (Einstein and McDaniel 1996; Einstein et al. 2005); the extent to 
which one or the other is engaged likely depends on the resource demands of the task 
(Einstein et al. 2005) and presence of external cues to aid retrieval (Nowinski and Dismukes 
2005).   Time-based PM tasks therefore employ greater strategic processing and self-
5 
 
initiated retrieval whilst event-based PM engages more automatic processing given its 
externally cued nature (Einstein and McDaniel 1990).   
 
Only a handful of studies have explored the effects of acute nicotine administration on PM 
in deprived smokers and most have used event-based tasks.  Rusted et al. (2005) used a 
lexical decision task with an embedded event-based PM task (in which participants made a 
response to certain target words or letters).  Improved PM performance in 2hr abstinent 
smokers was observed after smoking a cigarette.  In a later study using the same paradigm, 
nicotine nasal spray was also shown to improve PM performance in both abstinent smokers 
and non-smokers (Rusted and Trawley 2006). Using a virtual reality paradigm, the Jansari 
Assessment of Executive Functions (JEF), our group (Jansari et al. in press) has observed a 
facilitative effect of 4mg nicotine gum on event-based and time-based PM in 2hr abstinent 
smokers.  Whether nicotine is effective in improving PM will likely depend on the speed and 
efficacy of nicotine delivery to the blood and in turn, engagement with neurotransmitter 
systems; this may depend on the mode of nicotine administration with more rapid nicotine 
delivery systems (e.g. smoking, subcutaneous, nasal spray) arguably having a greater effect.   
Electronic cigarettes are novel nicotine delivery devices which, although unregulated and 
unlicensed for cessation, are used by smokers as alternatives to smoking, for quitting 
smoking  or to prevent relapse (Etter and Bullen 2011a; Dawkins et al. under review).  Their 
absolute safety and efficacy remain unknown although their potential for smoking 
cessation/harm reduction is worthy of further exploration.   
 
In order for e-cigarettes to be viewed as an effective smoking cessation/harm reduction 
method, they should deliver consistent and sufficiently high levels of nicotine to the blood, 
while simultaneously reducing the desire to smoke and tobacco withdrawal symptoms 
including the mild cognitive deficits experienced during abstinence. Reports regarding 
delivery to the blood stream are inconsistent; three human studies reported very low blood 
nicotine levels in naive users (Bullen et al. 2010; Eissenberg 2010; Vansickel et al. 2010) 
whilst significant increases in salivary cotinine (a nicotine metabolite; Etter and Bullen 
2011b) and blood nicotine levels (Vansickel and Eissenberg 2012) have been shown in 
regular users.  E-cigarettes have been observed to reduce craving/desire to smoke in naive 
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users (Bullen et al. 2010; Dawkins et al. 2012; Vansickel et al. 2010) but in some cases, this 
was also found with the placebo (0mg nicotine) e-cigarette (Dawkins et al. 2012).  Likewise, 
alleviation of withdrawal symptoms did not always differ between placebo and nicotine e-
cigarette conditions (Bullen et al. 2010; Dawkins et al. 2012).  Dawkins et al. (2012) observed 
a significant reduction in anxiety, poor concentration, irritability and restlessness with 
nicotine versus placebo e-cigarette but this was only in males.  This study was also the first 
to explore effects of the e-cigarette on cognition by including tasks tapping attention/speed 
of processing (letter cancellation) and working memory.  Whilst attention was not affected, 
recall on the working memory task was consistently higher in the nicotine group with 
significant differences emerging with longer periods of interference (i.e. more effortful 
processing).   
 
We have previously argued (e.g. Dawkins et al. 2007) that cognitive impairments in smokers 
should be most readily observable during abstinence when background neurotransmitter 
levels (e.g. dopamine, acetylcholine) are low, compared to after recent nicotine ingestion 
when neurotransmitter release is stimulated.  If the e-cigarette is an effective nicotine 
delivery tool then we would expect alleviation of abstinence-related negative mood and 
impaired cognition.  The present study therefore aimed to explore whether the nicotine e-
cigarette improved PM (assessed using the Cambridge Prospective Memory Test, 
CAMPROMPT; Wilson et al. 2005) tobacco-related withdrawal symptoms and desire to 
smoke in abstinent smokers using a double-blinded, placebo-controlled, within-subjects 
design.   
 
Method  
Participants 
Participants were 20 smokers (all Caucasian; 17 employed; 13 female) with a mean age of 
31.85 years (SD = 8.7), recruited via advertisements, social network forums, e-mail and word 
of mouth.  All smoked within an hour of waking, smoked more than 10 cigarettes a day and 
had done so for at least one year.  
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Design and Data Analysis 
A within-subjects design was employed; each participant was tested on two occasions after 
overnight abstinence, with e-cigarette type (nicotine vs placebo; order counterbalanced) as 
the independent variable.  The placebo condition therefore represents the ‘abstinent’ state. 
Dependent variables were the CAMPROMPT time-based and event-based PM scores, desire 
to smoke and tobacco withdrawal symptom (MPSS) ratings.  Desire to smoke and MPSS 
variables were analysed using repeated measures analysis of variance with e-cigarette order 
(nicotine first vs. placebo first) as a between subjects variable.  Test order (version A first vs. 
version B first) was included as an additional between subjects for CAMPROMT PM. 
 
Materials 
The e-cigarette 
The 'Tornado' e-cigarette was supplied by Totally Wicked E-Liquid (TWEL).  E-cigarettes were 
fully charged prior to each assessment session and fitted with either an 18mg (nicotine) or 0mg 
(placebo) cartridge, both of which were tobacco flavoured. 
  
Breath CO sampling 
 Participants were asked to breathe into a Bedfont micro-Smokerlyser for 10 seconds to 
confirm their abstinence status (< = 10 ppm). 
 
 
Baseline assessment measures 
Demographic information including age, gender, ethnicity and occupation status was 
collected. 
 
The Fagerström Test of Nicotine Dependence (FTND; Heatherton et al. 1991). A six-item 
self-report scale to assess nicotine dependence.  Scores can range from 0 (low 
dependence) to 10 (high dependence).  
 
Dependent variables 
Desire to Smoke  
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Participants rated their current desire for a cigarette using the single-item 'how strong is 
your desire to smoke right now?' on a 7-point Likert scale ranging from 'not at all strong' 
(scored 1) to 'extremely strong' (scored 7).  
 
Mood and Physical Symptoms Scale (MPSS; West and Hajek 2004).  
The MPSS was used to measure signs and symptoms commonly associated with tobacco 
withdrawal.  Six items (depressed mood, irritability, restlessness, anxiety, drowsy, difficulty 
concentrating and hunger) are each rated on a 5-point Likert  scale ranging from  'not at 
all' (scored 0) to 'extremely' (scored 4).  A total score in addition to individual items can be 
computed with scores ranging from 0 to 28. 
 
The Cambridge Prospective Memory Test (CAMPROMPT; Wilson et al. 2005). The 
CAMPROMPT comprises six prospective memory tasks which are either cued by events 
(event-based PM tasks; N = 3) or by time (time-based PM tasks; N = 3). There are two 
parallel versions of the test, A and B, which differ only slightly and have been shown to 
have a high inter-rater reliability, test-retest reliability and parallel form reliability. The 
inter-rater reliability from the control group showed a correlation between scores of 0.998 
(Wilson et al. 2005). Such a high correlation shows that the scoring system devised and 
described in the CAMPROMPT is both easy to implement and highly reliable. The test-
retest controls’ performances revealed, as expected, there was a practice effect (z=-3.26, 
p=0.001) however, this was small in magnitude (mean increase = 3.8).  For the parallel 
form reliability there was no significant differences in performance for the group as a 
whole, for those who did version A first or for those who did version B first, indicating that 
either version can be given to a participant without the results being significantly affected.   
 
Participants work on a number of 'background' distractor pencil and paper tasks such as a 
general knowledge quiz or word finder puzzle for 20 minutes. While they are engaged with 
this, they are asked to remember to do other tasks such as reminding the experimenter of 
something, either during the 20 minute session or shortly after it finishes.  Strategies to aid 
memory, for example writing a reminder on the paper provided, are permitted.   The time 
interval between being asked to do the task and responding appropriately at the right 
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moment are balanced across the cueing conditions. One of the event-based tasks (return a 
book or keys to the experimenter) is cued by a specific quiz question, one (give a message) 
by the 'beeper' going off followed by a prompt from the experimenter, and one (find 
hidden objects) by a statement from the experimenter to say that the session is over.  Two 
of the three time-based tasks (remind experimenter not to forget her keys/mug when 
there are 7 minutes left until the end of the session; when timer shows 16 mins, change 
tasks) are cued by a countdown kitchen timer and the third (remind experimenter to 
telephone reception/garage) is cued by a clock.  Both the clock and the timer are on the 
table in front of the participant. Scores for each subtask can range from 0 to 6.  Six points 
are awarded if the participant successfully completes the task unaided; four points are 
awarded if the tasks are completed after the experimenter provides a single general 
prompt; two points if it is completed after a second more specific prompt and no points if 
the participant fails to complete the task after two prompts.   Total time-based and event-
based CAMPROMPT PM scores were calculated by summing the three time- and event-
based scores for each session, thus scores could range from 0 to 18 with a higher score 
indicating better PM.  Overall total PM was calculated by summing these two.   
 
 Procedure  
Participants were asked to remain abstinent overnight (i.e. not to smoke for 8-10 hours) 
prior to testing on two separate mornings one week apart.  Upon arrival at the lab at time 1, 
participants provided written informed consent and provided a breath sample to confirm 
compliance with the instructions to remain abstinent from smoking.  The experimenter then 
introduced the participant to the e-cigarette explaining and demonstrating how to use it 
before allowing the participant to use it ad libitum for ten minutes.  Participants were then 
asked to wait for 15 minutes (to allow time for the nicotine to reach maximum plasma 
concentration; Bullen et al. 2010; Vansickle and Eissenberg 2012) during which time they 
completed basic demographic information and the FTND (time 1 only).  After 15 minutes, 
participants then completed the MPSS and desire to smoke scales followed by the 
CAMPROMPT. 
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Testing at time 2 followed the same procedural format using the parallel version of the 
CAMPROMPT (order counterbalanced), although the demographic questionnaire and the 
FTND were not repeated. At the end of the second session, participants were debriefed 
and asked to guess on which occasion they had received nicotine and placebo and then 
informed accordingly.   Each testing session lasted approximately one hour.  
 
The study was granted ethical approval by the University of East London Ethics Committee 
and was performed in accordance with the ethical standards laid down in the 1964 
Declaration of Helsinki. 
 
Results  
Demographics 
Participants were moderately dependent on nicotine as indexed by a mean FTND score of 
4.55 (SD: 1.90). Participants complied with the instruction to remain abstinent prior to both 
testing occasions with a mean CO level of 6.55 (SD: 1.47) prior to the nicotine condition and 
6.15 (SD) prior to placebo.  
Manipulation Check 
Participants were asked at the end of the second session to guess on which occasion they 
had received nicotine and placebo.  Guessing was at chance level with eight participants 
guessing correctly, nine guessing incorrectly and 3 reporting that they did not know.  
MPSS and craving 
Table 1 displays mean desire to smoke and MPSS scores across the nicotine and placebo e-
cigarette conditions. All variables were normally distributed.  Desire to smoke and overall 
symptom reporting (total MPSS score) were both significantly higher in the placebo 
condition (F (1,18) = 11.78, p = 0.003 & F (1,18) = 12.17, p = 0.003 respectively).  
Examination of individual withdrawal symptoms revealed that only anxiety differed 
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significantly across conditions with higher anxiety in the placebo condition (F (1,18) = 6.82, p 
= 0.018).  On no occasion was there a significant interaction with e-cigarette order.   
CAMPROMPT 
All CAMPROMPT variables were normally distributed.  Overall PM performance was better 
under nicotine (mean = 28.50; SD = 4.19) than placebo (mean = 27.40; SD = 4.37).  ANOVA 
revealed that the main effect of e-cigarette type was statistically significant (F (1,16) = 4.44, 
p = 0.05).  Separate analysis for time-based and event-based PM revealed significantly 
better performance with nicotine for the former (F (1,16) = 5.08, p = 0.04) but not the latter 
(F (1,16) = 0.12, p > 0.05; see Figure 1).  Event-based PM performance was however, close to 
ceiling under placebo with six participants scoring the maximum score of 18 and a further 5 
scoring 16.   There were no interactions between e-cigarette type and either e-cigarette 
order or test order for any variable.   
 
Finally, to explore the relationship between nicotine dependence and PM performance, 
Pearson correlations were performed between FTND and CAMPROMPT scores under both 
nicotine and placebo conditions.  There was a moderate negative correlation between FTND 
and total time-based PM under placebo which approached significance (r = -0.41, p =0.07).  
All other correlations were non-significant (r < 0.38, p > 0.10).  
 
Discussion 
  
This is the first study to explore effects of nicotine delivered via the e-cigarette on PM. 
Under double-blinded, placebo controlled conditions, the nicotine e-cigarette improved 
time-based (but not event-based) PM, desire to smoke and tobacco withdrawal symptoms 
in abstinent smokers.  These findings suggest that that the electronic cigarette can 
effectively deliver nicotine to impact on cognitive performance although concurrent 
measurement of blood nicotine levels would be useful to verify this. 
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Whilst previous studies have also found positive effects of nicotine on PM, there are some 
subtle differences.  The facilitative effect of nicotine on PM was observed here on time-
based but not event-based tasks.  This is in contrast to Rusted’s group (Rusted et al. 2005, 
2009; Rusted and Trawley 2006) who have not included time-based tasks but who have 
found improvements with nicotine on event-based PM, and with Jansari et al. (in press) who 
found effects of nicotine gum on both event- and time-based tasks with comparable effect 
sizes.   That differences have emerged between these studies is not surprising given the 
different methods of nicotine administration and heterogeneous PM tasks employed which 
vary in the extent to which they engage strategic processing.  Nevertheless, whilst the exact 
nature and mechanism of the nicotine effect requires elucidation, a consistent picture of 
nicotinic enhancement of PM is beginning to emerge.   
 
Overall performance on event-based compared to time-based PM was generally much 
better, with performance close to ceiling, and this may have accounted for the lack of 
improvement by nicotine.  Better performance on event-based compared to time-based PM 
has previously been observed on the CAMPROMPT in smokers, non-smokers (Heffernan et 
al. 2010), ecstasy/polydrug users or cannabis users (Hadjiefhyvoulou et al. 2011) and is 
consistent with the multi-process model of PM which proposes relatively greater 
involvement of either strategic or automatic processing in the retrieval of intentions 
depending on the resource demands of the task and salience of external cues (Einstein and 
McDaniel 1990; McDaniel and Einstein, 2000).  Thus the greater saliency of the cue in event-
based tasks is proposed to trigger automatic or reflexive retrieval of the intention with 
active engagement of attention.  Time-based PM by contrast, involves greater strategic 
processing/external monitoring due to the reduced saliency or absence of cues which places 
greater demand on attentional resources.  
 
The finding that nicotine improved performance on time-based rather than event-based PM 
in the present study is consistent with this automatic versus strategic dissociation and with 
the generally accepted view that nicotine, via facilitation of cholinergic transmission, is 
implicated in the selective enhancement of strategic, effortful-based, working-memory 
processing rather than more automated processing (Rusted et al. 2005; Sahakian 1998).  
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This has been demonstrated using a number of different paradigms, including retrieval 
induced forgetting (Edginton and Rusted 2003), the antisaccade task (Dawkins et al. 2007), 
the n-back task (Ernst et al. 2001) and most recently by Dawkins et al. (2012) using the 
Trigram working memory task in which the nicotine e-cigarette improved performance 
when the demands of the task increased, stretching resources.  Nevertheless, this 
conclusion remains speculative pending replication of this study, utilizing more effortful on-
going tasks in order to reduce the high scores observed on the event-based tasks.   
 
An alternative explanation for the enhancing effects of nicotine on PM based on fMRI 
findings, is forwarded by Rusted et al. (2011).  It is proposed that nicotine modulates covert 
attentional reorientation of resources towards PM targets via accelerating deactivation of 
the default resting brain network (Hahn et al 2007).  This is achieved through 
downregulating activity in parietal regions.  This proposal, however, is based purely on the 
event-based approach to exploring PM thus it is unclear whether this explanation would 
extend to the effects of nicotine on time-based tasks where cues are absent.  
 
 The findings of the present study are interpreted within the context of a ‘reversal of 
abstinence-induced deficits’ model, that is prospective memory is impaired during 
abstinence from smoking and the nicotine e-cigarette is capable of reversing this 
impairment.  It is possible, however, that nicotine may confer a benefit over and above a 
reversal of deprivation-associated deficits as is suggested by facilitative effects of nicotine in 
minimally (2hr) deprived smokers and non-smokers (Rusted  and Trawley 2006; Rusted et al. 
2009).  Ascertaining such a ‘true’ facilitative effect of nicotine was beyond the scope of this 
study but it would be interesting to determine whether nicotine derived via the e-cigarette 
can improve PM in non-smokers and potentially offer another pharmacological intervention 
to promote cognitive functioning in older adults. 
 
Whilst acute doses of nicotine can improve PM, there is some evidence that chronic 
smoking can impair it. Heffernan et al. (2010) and Heffernan and O’Neill (2012) have 
reported impaired PM in current smokers compared with never-smokers and number of 
years smoked correlated negatively with performance on the CAMPROMPT suggesting that 
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a longer smoking history is associated with greater PM impairment.  Consistent with this 
notion, here we observed a moderate but only marginally significant negative correlation 
between nicotine dependence (as assessed by the FTND) and time-based prospective 
memory under the placebo (abstinent) but not nicotine condition.  Theoretically, this 
pattern of findings makes sense since it is during abstinence, rather than after acute drug 
ingestion, that underlying abnormalities of brain functioning are likely to be unmasked 
(Altmann et al. 1996; Volkow et al. 2004) with greater severity of dependence associated 
with more severe brain abnormalities (Moreno-López et al. 2012).  Nevertheless, given that 
passive smoking has also recently been associated with impaired self-report PM (Heffernan 
and O’Neill 2012), is it unclear whether the nicotine per se or some other aspect of tobacco 
smoking is responsible for the PM deficit.   
 
The present study also aimed to explore effects of the nicotine e e-cigarette on desire to 
smoke and tobacco withdrawal symptoms and to clarify some of the previous discrepant 
findings using a better-designed (placebo-controlled, double-blinded, within-subjects) study.  
The highly significant reduction in desire to smoke, despite the fact that participants were 
unable to accurately detect on which occasion they had received nicotine, is consistent with 
previous studies that the nicotine e-cigarette is capable of reducing tobacco craving in 
abstinent smokers (Bullen et al. 2010; Dawkins et al. 2012; Vansickel et al. 2010).  Total 
MPSS scores were also significantly lower in the nicotine versus the placebo condition 
consistent with an attenuating effect of the nicotine e-cigarette on tobacco-related 
withdrawal symptoms.  Inspection of individual symptoms however, revealed that only 
anxiety benefitted from a significant improvement with nicotine.  Given that our previous 
study found greater alleviation of withdrawal symptoms in males, (Dawkins et al. 2012) this 
may reflect the larger proportion of females in the current study.  That there was no effect 
of nicotine on self-reported ability to concentrate is surprising given the facilitative effect of 
nicotine on PM.  This may reflect the possibility that smokers lack insight into their cognitive 
state or might be a consequence of the small sample size; with only 20 smokers completing 
both conditions, there may be insufficient power to detect an effect on individual aspects of 
tobacco-related withdrawal symptoms.   
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To conclude, consistent with a growing body of evidence suggesting that nicotine can 
improve PM, this study observed a facilitative effect of nicotine delivered via e-cigarette on 
time-based PM in abstinent smokers.  That the improvement was associated with time-
based rather than event-based PM is consistent with suggestions that nicotine improves 
performance when strategic/effortful processing is employed but it could also reflect a 
ceiling effect observed here.  The nicotine e-cigarette also alleviated desire to smoke and 
tobacco withdrawal symptoms.  Taken together, these findings provide further evidence 
that nicotine delivery via the electronic cigarette is an effective ameliorator of negative 
mood and mild cognitive impairment associated with tobacco abstention.   
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Table 1: Mean and SD Desire to smoke and MPSS variables under nicotine and placebo e-cigarette 
conditions 
 Nicotine Placebo 
 Mean SD Mean SD 
Depressed 0.45 0.69 0.45 0.69 
Irritable 0.70 0.86 0.80 1.01 
Anxious 0.10* 0.31 0.35 0.59 
Drowsy 0.20 0.52 0.30 0.57 
Restless 1.05 1.00 1.15 0.88 
Hungry 1.25 1.07 1.30 1.08 
Unable to concentrate 0.65 0.81 0.70 0.80 
MPSS Total 4.35** 2.92 5.00 3.03 
Desire to smoke 4.20** 1.79 4.80 1.58 
*p<0.05; **p<0.01 
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Figure 1: Mean time-based and event-based PM scores under nicotine and placebo conditions (error 
bars = 1SE) 
 
